STERIS plc Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 20 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-12-13: Reporting owner Zangerle John Adam; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-12-08: Reporting owner Carestio Daniel A; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-11-15: Reporting owner Zangerle John Adam; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-11-03: Reporting owner FELDMANN CYNTHIA L; Form 4; Security Director Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-12-13 | Zangerle John Adam Officer (VP, Gen Counsel, and Sec.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,100 0 owned after | $30.84 exercise price | 2016-12-14 | |
| 2016-12-08 | Carestio Daniel A Officer (Sr. V. P., Isomedix & Life Sci) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,225 0 owned after | $29.94 exercise price | 2016-12-09 | |
| 2016-11-15 | Zangerle John Adam Officer (VP, Gen Counsel, and Sec.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,200 0 owned after | $27.68 exercise price | 2016-11-16 | |
| 2016-11-03 | FELDMANN CYNTHIA L Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,744 0 owned after | $34.17 exercise price | 2016-11-07 | |
| 2016-08-10 | Wood Michael B Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,781 3,781 owned after | $71.40 exercise price | 2016-08-11 | |
| 2016-08-10 | WILSON LOYAL W Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,781 3,781 owned after | $71.40 exercise price | 2016-08-11 | |
| 2016-08-10 | WAREHAM JOHN P Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,462 5,462 owned after | $71.40 exercise price | 2016-08-11 | |
| 2016-08-10 | Steeves Richard Martin Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,781 3,781 owned after | $71.40 exercise price | 2016-08-11 | |
| 2016-08-10 | Sohi Mohsen Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,781 3,781 owned after | $71.40 exercise price | 2016-08-11 | |
| 2016-08-10 | KOSECOFF JACQUELINE B Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,781 3,781 owned after | $71.40 exercise price | 2016-08-11 | |
| 2016-08-10 | FELDMANN CYNTHIA L Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,781 3,781 owned after | $71.40 exercise price | 2016-08-11 | |
| 2016-08-10 | Breeden Richard C Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,781 3,781 owned after | $71.40 exercise price | 2016-08-11 | |
| 2016-06-01 | Zangerle John Adam Officer (VP, Gen Counsel, and Sec.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $69.72 exercise price | 2016-06-02 | |
| 2016-06-01 | Khan Gulam Amjad Officer (Sr. V.P., Procedural Solutions) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $69.72 exercise price | 2016-06-02 | |
| 2016-06-01 | TOKICH MICHAEL J Officer (SVP, CFO & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $69.72 exercise price | 2016-06-02 | |
| 2016-06-01 | Forsythe Suzanne V Officer (V. P. - Human Resources) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $69.72 exercise price | 2016-06-02 | |
| 2016-06-01 | Bardwell Kathleen Officer (Sr.V. P. & C.C.O.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | +7,000 7,000 owned after | $69.72 exercise price | 2016-06-02 | |
| 2016-06-01 | Carestio Daniel A Officer (Sr. V. P., Isomedix & Life Sci) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $69.72 exercise price | 2016-06-02 | |
| 2016-06-01 | Rosebrough Walter M Jr Director, Officer (President & CEO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +112,340 112,340 owned after | $69.72 exercise price | 2016-06-02 | |
| 2016-06-01 | Pahwa Sudhir K Officer (Sr. V.P., IPT) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $69.72 exercise price | 2016-06-02 |